News

Who Will be Making News Next Month?

What’s Happening in the Month Ahead: December 2017

By Rich Kirkner | December 6, 2017

Can Conference Save Orphan Drug Tax Credit? Orphan drug developers will be watching closely in the next few days as the GOP’s tax reform package…

Read More
OIS-Index-Article

OIS Index Outperforms Biotech Stocks for Third Straight Month

By Michael Lachman | December 6, 2017

For the third straight month, the OIS Index outperformed the NASDAQ Biotechnology Index. The OIS Index gained 2.6% in November, nearly matching the performance of…

Read More
Why The “Digital Natives” Are Restless

Masters of Industry: Digitization, Millennials, and the Future of Device and Pharma

By Rich Kirkner | November 29, 2017

The forces driving ophthalmic innovation are digitization and demographics, namely in the emergence of millennials, and how the major players in ophthalmology respond to those…

Read More
Seen and Heard at AAO 2017: Reporter’s Notebook

Seen and Heard at AAO 2017: Reporter’s Notebook

By Rich Kirkner | November 15, 2017

Here’s a review of clinical trial results and new technology rolled out at the latest gathering of the American Academy of Ophthalmology in New Orleans.…

Read More
Workshop’s Message: Handle Data with Care

Workshop’s Message: Handle Data with Care

By Karen Blum | November 8, 2017

GAITHERSBURG, MD – Digital Health devices can help detect eye disease in various health-care settings, although ophthalmic practices need to carefully monitor data they generate,…

Read More
OIS-Index-Article

OIS Index Outperforms Biotechs but Lags Devices and Broader Market in October

By Michael Lachman | November 2, 2017

The OIS Index is a composite of ophthalmic growth stocks that tracks the investment performance of our sector. Our goal is to highlight ophthalmology investment…

Read More

What You’ll Miss if You’re not at OIS@AAO 2017

By Rich Kirkner | November 1, 2017

Let’s just say there’s too much happening at OIS@AAO 2017 next week to capsulize it all in a tidy preview, but with the ninth iteration…

Read More
Learn how the Ophthalmic Digital Health workshop fits with the FDA Commissioner's vision

Workshop Part of Gottlieb’s Digital Plan

By Karen Blum | October 18, 2017

When Food and Drug Administration Commissioner Scott Gottlieb, MD, announced a new agency-wide initiative last summer called the Digital Health Innovation Plan, the goal was…

Read More
Wall Street's price speculation about Spark Therapeutics’ Luxturna gene therapy

Putting a Price on FDA’s Nod to Spark Therapeutics

By Rich Kirkner | October 18, 2017

With the unanimous endorsement from a Food and Drug Administration advisory committee that Spark Therapeutics’ Luxturna gene therapy for biallelic RPE65 mutation-associated retinal dystrophy should…

Read More
Ophthalmic Digital Health

FDA-led Workshop Puts Focus on Ophthalmic Digital Health

By Steve Lenier | October 11, 2017

The workshop on Ophthalmic Digital Health, a collaboration of the Food and Drug Administration and a host of medical societies that aims to explore safety…

Read More
Who Will be Making News Next Month?

Who Will be Making News in October?

By Rich Kirkner | October 4, 2017

What’s Happening in the Month Ahead: October 2017 The Food and Drug Administration along with a host of professional societies, including the American Academy of…

Read More
OIS-Index-Article

Solid September Closes OIS Index 1st Year

By Michael Lachman | October 4, 2017

One year ago, we launched the OIS Index, a composite of ophthalmic growth stocks, to track the investment performance of our sector. Our goal is…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.